Measurements of Doppler Signals Noninvasively From the Lung in Congestive Heart Failure
Evaluation of Lung Doppler Signals in Congestive Heart Failure(CHF)
1 other identifier
observational
50
1 country
1
Brief Summary
The purpose of this study is to evaluate the lung Doppler signals in left HF patients with and without pulmonary congestion (i.e. decompensated left HF patients and compensated left HF patients respectively), in comparison to a control group of subjects without CHF (non-CHF controls), in order to determine the diagnostic value of this non-invasive method in CHF. If this method will prove to be of diagnostic value, it could potentially be used to diagnose and monitor CHF patients in both inpatient and outpatient settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2013
CompletedFirst Posted
Study publicly available on registry
September 12, 2013
CompletedStudy Start
First participant enrolled
October 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedFebruary 8, 2017
August 1, 2013
2.2 years
September 9, 2013
February 7, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnose specific pattern of LDS in patients by features as velocity, power etc in comparison to controls
1.5y to collect all data and obtain a diagnostic pattern
Study Arms (3)
Decompensated CHF
patients with acute pulmonary congestion or pulmonary edema
Compensated CHF
patients with significant stable left HF (NYHA II-III) who are on optimal medical treatment for CHF, and are without clinical or laboratory evidence of pulmonary congestion
Non CHF patients
patients without CHF and without uncontrolled hypertension.
Interventions
Eligibility Criteria
A total of 150 mpatients will be recruited during 18 months: 50 Acute decompensated left heart failure;50 compensated left heart failure;50 non-CHF controls.
You may qualify if:
- Age over 18 years
- Belongs to one of the following categories:
- A. Acute decompensated left HF: patients with acute pulmonary congestion or pulmonary edema diagnosed on the basis of all of the following criteria:
- Dyspnea at rest or with minimal activity
- Rales on auscultation
- Evidence of pulmonary congestion or edema on chest X-ray.
- BNP level \>400 pg/ml
- B. Compensated left HF: patients with significant stable left HF (NYHA II-III) who are on optimal medical treatment for CHF, and are without clinical or laboratory evidence of pulmonary congestion. The following 3 criteria must be met:
- No dyspnea at rest
- No rales on auscultation
- BNP levels \< 100 pg/ml
- C. Non-CHF controls: patients without CHF and without uncontrolled hypertension.
- Signed Informed Consent
You may not qualify if:
- \- Decompensated left HF subgroup \& Non CHF controls
- Non-cardiogenic pulmonary edema or lung injury (e.g. ARDS)
- Interstitial lung disease
- Severe kyphosis, scoliosis or chest wall deformity
- Pregnant women
- Compensated left HF subgroup
- Chronic obstructive pulmonary disease (COPD)
- Asthma
- Interstitial lung disease
- Any other obstructive or restrictive lung diseases
- Non-cardiogenic pulmonary edema or lung injury (e.g. ARDS)
- Current or past pulmonary embolism
- Large right sided pleural effusion
- Severe kyphosis, scoliosis or chest wall deformity
- Pregnant woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Echosense Ltd.lead
Study Sites (1)
EMD Rambam Hospital
Haifa, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shmuel Rispler, MD, PhD
Rambam Health Care Campus
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Days
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2013
First Posted
September 12, 2013
Study Start
October 1, 2013
Primary Completion
December 1, 2015
Study Completion
March 1, 2016
Last Updated
February 8, 2017
Record last verified: 2013-08